Navigation Links
Engineered virus targets and kills apparent cancer stem cells in neuroblastoma
Date:1/20/2009

target cells that contain the nestin protein. Next to rQNestin34.5, rQLuc showed only moderate success, with all treated mice having tumor formation within 40 days. In mice where cells were treated only with saline, all animals had tumors form within 30 days.

Although a promising step forward, Dr. Cripe said the study's main limitation is that precancerous cells were infected with the oncolytic virus in a laboratory culture before being injected into mice.

"Targeting and hitting the cells after they are already in the mice will be another matter," he said.

The research team also nurtured the stem-cell like tumorigenic cultures over an extended period of time in the laboratory. In the next research phase, the team will try to verify results in the current study by seeing if they can detect the presence of cancer stem cells in primary neuroblastoma tumor cells from patients.

Dr. Cripe cautioned much more research is needed before determining whether rQNestin34.5 would be efficacious in treating neuroblastoma patients in a clinical setting.


'/>"/>

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. FDA Issues Final Regulations for Genetically Engineered Animals
2. E. coli engineered to produce important class of antibiotic, anti-cancer drugs
3. Top Athletes Join Forces for a New Mission: Athlete-Engineered Skincare to Support Performance and Benefit Charity
4. FDA Proposes Regulations for Genetically Engineered Animals
5. Tumor suppressor genes speed up and slow down aging in engineered mouse
6. OrbusNeich Receives Approval to Market Genous(TM) Bio-engineered R stent(TM) in Taiwan
7. Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
8. Reconstructing mandibular defects with bioengineered tooth and bone
9. Nanomedicine system engineered to enhance therapeutic effects of injectable drugs
10. 5,000 Patients Treated With OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Now Enrolled in Real-Life Use Global Registry
11. T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , ... July 03, 2015 , ... ... enrollment on July 2nd creating a buzz of media attention. In an effort ... online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling overwhelmed ...
(Date:7/3/2015)... ... ... Scientists at several top US cancer centers believe they now know why certain ... to read the complete story , just posted on the Surviving Mesothelioma website. ... New York University exposed mice with a mutation on the tumor suppressor gene called ...
(Date:7/3/2015)... Lenexa, KS (PRWEB) , ... July 03, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... Okla. One of the top-ranked executive search firms in the healthcare industry, B. ...
(Date:7/3/2015)... MO (PRWEB) , ... July 03, 2015 , ... Talcum ... website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as the ... talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning information. ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ... the latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert ... selfie sticks are great for documenting memories. , Almost every smartphone has an incredibly ...
Breaking Medicine News(10 mins):Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Learn How to Take Selfies like Kendall Jenner 2
... a groundbreaking experiment published in Cloning & Stem Cells, ... unique embryonic stem cell lines that open the door ... provoke an immune reaction in large segments of the ... they have a simple genetic profile in the critical ...
... struggle to increase their pace, cyclists who cant pedal any ... from the University of Exeter and Kansas State University have ... we push ourselves during exercise. , We all have ... power. This level can increase as we get fitter, but ...
... leading,provider of clinical software, connectivity and information ... announced that the company,s,TouchWorks(TM) Electronic Health Record ... its market segment by the prestigious research ... TouchWorks earned the "Best in KLAS" ...
... 3 Program for Lead Product, MENLO ... announced today that it has completed a ... the clinical development of the company,s,novel antiplatelet ... The Series C financing was led ...
... For U.S. veterans with diabetes, lower scores on a ... increased risk of major amputations, reports a study in ... , "Our findings suggest that foot care programs need ... risk factor and to develop appropriate interventions to counteract ...
... CIGNA denies, GLENDALE, Calif., Dec. 20 ... will march on the corporate offices of ... to protest the company,s,denial of a life-saving ... Nurses Association/National Nurses Organizing,Committee announced today. The ...
Cached Medicine News:Health News:Human embryonic stem cell lines created that avoid immune rejection 2Health News:Why exertion leads to exhaustion 2Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 2Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 3Health News:Cogentus Pharmaceuticals Completes $62.5 Million Private Financing 2Health News:Mental health linked to amputation risk in diabetic veterans 2Health News:Life Denied: California Nurses, Family of Sick Teen March on Health Insurance Company Thursday 2
(Date:7/3/2015)... 2015 Redwood Pharma AB has ... Ltd., operating in both the US and ... ® supramolecular hydrogel technology in its lead chronic ... therapies. The Broda technology offers many unique competitive benefits. ... liquid and with low concentrations of polymer the system ...
(Date:7/2/2015)... ResMed Inc. (NYSE: RMD ) today announced that it ... 30, 2015 results on Thursday, July 30, 2015, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
(Date:7/2/2015)... , July 2, 2015 Roche,s ... conspicuously high-growth market segment in hematology testing, according ... said that Roche,s recent unveiling of its Bloodhound digital ... cobas m 511 hematology analyzer – ... capture growth enjoyed by current leader CellaVision, but ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... , WILMINGTON, Del. , Jan. ... plans have been approved by the Food & Drug Administration since their ... and report on how well these plans have actually been working in ... will be the topic of an open industry webinar at 12 ...
... , ST. LOUIS , Jan. 12 ... entered a distribution agreement with Eka Chemicals to offer Eka,s ... small molecules, peptides and proteins in the pharmaceutical and biotechnology ... and Puerto Rico , and expands Sigma-Aldrich,s portfolio ...
Cached Medicine Technology:REMS Assessment Webinar to Examine How to Measure Effectiveness of Drug Safety Plans 2Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals 2Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals 3Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals 4
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
Profix total knee system is intended for cemented use only....
The LCS complete knee offers grit-blast textured components for cemented implantation and POROCOAT Porous Coated patellar, femoral and tibial components for cementless fixation....
Primary and Posterior Stabilized Components....
Medicine Products: